TGA Australia Medical Device Registration & Approval

Australia medical device registration and ARTG inclusion

The Therapeutic Goods Administration regulates medical devices and IVDs under the Therapeutic Goods Act and Medical Devices Regulations. Most devices need inclusion in the ARTG before import/supply unless an exclusion, exemption or other lawful access arrangement applies. An overseas certificate does not itself include the product in the ARTG.

The TGA overview separates manufacturer conformity evidence from the Australian sponsor’s inclusion application. Plan both workstreams and the Essential Principles evidence before promising a commercial launch date.

Australian device and IVD classification

Apply the Australian IVD rules or the appropriate general-device rules to the actual intended use, technology and risk. Confirm the current treatment of legacy certificates and any product-specific transition. A foreign classification is useful background but not the Australian legal result.

Conformity evidence and manufacturer evidence

The manufacturer must apply the appropriate conformity-assessment procedures and hold evidence supporting compliance with the Essential Principles. Depending on the product and route, acceptable evidence can include TGA conformity-assessment certification or the specified comparable-overseas-regulator evidence. Scope, class, site, certificate type and accompanying product-assessment evidence matter.

Where required, the sponsor submits acceptable manufacturer evidence and obtains its acceptance before the ARTG application. This is not the same as a new Australian product approval. Some lower-risk self-declaration routes have different evidence arrangements; do not impose one universal manufacturer-evidence package on every Class I or Class 1 IVD.

Our sponsor/manufacturer-evidence guide explains the interfaces. A generic ISO 13485 certificate or reference-market authorization must not be described as universally sufficient for every Australian device or IVD.

ARTG application and application audit

The inclusion process starts with the sponsor, product classification, appropriate evidence and the correct kind-of-device scope. Grouping generally considers the sponsor, manufacturer, class and nomenclature, with additional requirements for higher-risk categories. A catalogue family is not automatically one ARTG entry.

Complete the application declarations accurately, pay applicable fees and respond to any audit or information request. Mandatory and discretionary application-audit requirements depend on the actual product/evidence case. Do not promise an audit waiver or one fixed review duration based only on a CE or FDA authorization.

Sponsor, labeling and lifecycle duties

The Australian sponsor is a local legal role with responsibilities for the application, supply and regulator communications. A distributor can be the sponsor, but define access to technical documentation, quality evidence, complaints, reportability, recalls, changes and record retention. The manufacturer retains its own conformity and safety obligations.

Review English product information, sponsor identification where required, models, intended use, warnings, software and UDI applicability against the actual ARTG scope. An entry generally continues subject to ongoing conditions and applicable annual charges; supporting certificates and records still require maintenance.

Costs and timeline planning

Separate evidence generation, conformity assessment, manufacturer-evidence processing, the ARTG application, audits and applicant responses. Government application/audit/annual charges differ from laboratory, certification and consulting costs. Use the current TGA fee category and a device-specific plan rather than one universal “registration cost.”

For Australia and New Zealand, technical evidence may be reused, but the sponsor roles, databases and reporting arrangements are separate. Pure Global can support the Australian pathway, evidence gap assessment, sponsor coordination and maintenance program.